Lascufloxacin

DB20002ExperimentalSmall molecule

Lascufloxacin is a small molecule drug. The usage of the INN stem '-oxacin' in the name indicates that Lascufloxacin is a nalidixic acid derivative antibacterial. Lascufloxacin has a monoisotopic molecular...

Formula / weight: C₂₁H₂₄F₃N₃O₄ · 439.435 g/mol (avg)

Resolves to

Compound

UNII55MOB566V7CAS848416-07-9ChEMBLCHEMBL6068006

Clinical / RWD

ATCJ01MA25

Structure

InChIKeyZFIOCUITTUUVPV-MEDUHNTESA-NSMILESCOC1=C2N(CCF)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1C[C@@H](F)[C@@H](CNC2CC2)C1

Transporters

P08183ABCB1Q9UNQ0ABCG2

What you can answer from here — as of September 16, 2026

2TransportersSubstrate / inhibitor direction, not just membership

Listed above

1ATC codeIncluding every combination product, plus 10 drug categories

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of Lascufloxacin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account